Disease/Infection News

RSS

EMA grants PRIME designation to Themis' chikungunya vaccine candidate

Themis announced today that the European Medicines Agency has granted PRIority MEdicines designation to its most advanced program in development, a vaccine to prevent chikungunya fever.

11 Jun 2018

Novel computer models for individualization of HIV therapy in countries with limited healthcare resources

New predictive computer models designed to optimize HIV therapy in countries with limited healthcare resources are published online this week in the Journal of Antimicrobial Chemotherapy.

11 Jun 2018

Researchers develop flexible "Plug and Play" technology to protect against emerging diseases

Researchers from GeoVax have developed a flexible "Plug and Play" technology platform that delivers single-dose vaccines that fully protect against emerging infectious diseases such as Zika, Lassa fever, and Ebola.

11 Jun 2018

Rural Vietnam village harbors multi-drug-resistant, colistin-resistant E. coli bacteria, shows study

A new study has found that the majority of residents in a rural village of Vietnam harbored multi-drug-resistant, colistin-resistant E. coli bacteria.

11 Jun 2018

Study: Small RNA chains could regulate the genes involved in salmonella's virulence

A series of small RNA fragments are the regulator factors involved in a new control mechanism for salmonella virulence, a pathogenic bacterium which causes bacterial gastroenteritis with a high incidence -more than 100,000 cases per year- in Europe

8 Jun 2018

Study shows absence of zoonotic parasitic worms in European farmed fish

A recent study conducted by the EU Horizon 2020-funded ParaFishControl project aimed to demonstrate the absence of zoonotic parasitic worms in European farmed fish, specifically in gilthead sea bream, European sea bass, turbot, Atlantic salmon, rainbow trout and common carp.

8 Jun 2018

Researchers identify oldest bubonic plague genome

An international team of researchers led by the Max Planck Institute for the Science of Human History has analyzed two 3,800-year-old Y. pestis genomes that suggest a Bronze Age origin for bubonic plague.

8 Jun 2018

Livestock may play important role in epidemiology of leptospirosis in sub-Saharan Africa

Leptospirosis, which affects more than one million people worldwide each year, is known to be transmitted to humans from a wide range of animals. Now, researchers reporting in PLOS Neglected Tropical Diseases have discovered that more than 7 percent of the cattle and 1 percent of sheep and goats in local slaughterhouses in northern Tanzania are infected with Leptospira bacteria.

8 Jun 2018

Study finds cattle as possible source of human leptospirosis in Africa

The bacterial infection leptospirosis is increasingly recognized as an important cause of fever in Africa. Now, researchers reporting in PLOS Neglected Tropical Diseases have analyzed the major risk factors for contracting leptospirosis and discovered that rice and cattle farming are associated with acute infection.

8 Jun 2018

Treating silent malaria cases could help stop spread of disease, shows study

In regions where malaria illness is widespread, it is common to find many individuals who are infected with malaria parasites, but without symptoms.

8 Jun 2018

New project maps impact of climate change on tropical diseases

The HEALTHY FUTURES project developed an online interactive atlas that maps and predicts the risk in eastern Africa of three deadly tropical diseases: malaria and Rift Valley fever, both transmitted by mosquitos, and schistosomiasis, which is caused by worms that emerge from freshwater snails.

7 Jun 2018

Mucus appears to protect flu virus when it becomes airborne, shows study

Mucus and other airway secretions that are expelled when a person with the flu coughs or exhales appear to protect the virus when it becomes airborne, regardless of humidity levels, a creative experiment conducted by the University of Pittsburgh and Virginia Tech discovered.

7 Jun 2018

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States, researchers from the Perelman School of Medicine at the University of Pennsylvania reported in a new study published in the journal Open Forum Infectious Diseases.

7 Jun 2018